Results 221 to 230 of about 5,039,222 (352)

Organized Colorectal Cancer Screening Programs in Switzerland - Quo Vadis? [PDF]

Int J Public Health
Albers B, Auer R, Selby K, Clack L.
europepmc   +1 more source

Lessons from Hereditary Colorectal Cancer

Cell, 1996
K. Kinzler, B. Vogelstein
semanticscholar   +1 more source

Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer

, 1982
Hans-Jürgen Staab, F. A. Anderer, A. Hornung, E. Stumpf, Rainer Fischer   +4 more
openalex   +2 more sources

Screening for colorectal cancer in a factory-based population with Fecatest [PDF]

, 1983
F I Lee
openalex   +1 more source

PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3

Advanced Science, EarlyView.
By decreasing cholesterol and lipid raft levels in the plasma membrane, proprotein convertase subtilisin/kexin type 9 (PCSK9) boosts human epidermal growth factor receptor 1 and 3 (EGFR and HER3) activation, driving tumor growth and metastasis in triple‐negative breast cancer (TNBC).
Tianhong Li, Renfei Wu, Kathy Qian Luo
wiley   +1 more source

FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration

Advanced Science, EarlyView.
USP42 is identified as a novel DUB of PPARγ in hepatocytes. USP42 mediated PPARγ deubiquitylation determines its transcriptional preference on proliferative and redox balance genes. USP42 knockdown exacerbates liver damage and delays regeneration. FGF2 is the upstream signal that initiates and activates the USP42‐PPARγ axis.
Nanfei Yang, Qiang Tian, Zhenli Lei, Shuxin Wang, Nan Cheng, Zhen Wang, Xianqin Jiang, Xuqun Zheng, Wenjing Xu, Minyan Ye, Longwei Zhao, Meiyun Wen, Jianlou Niu, Weijian Sun, Pingping Shen, Zhifeng Huang, Xiaokun Li   +16 more
wiley   +1 more source

Cytogenetic signatures favoring metastatic organotropism in colorectal cancer. [PDF]

Nat Commun
Golas MM, Gunawan B, Gutenberg A, Danner BC, Gerdes JS, Stadelmann C, Füzesi L, Liersch T, Sander B.   +8 more
europepmc   +1 more source

Screening for Liver Metastases from Colorectal Cancer with Carcinoembryonic Antigen and Alkaline Phosphatase

, 1981
Paul Ian Tartter, Gary Slater, Irwin M. Gelernt, Arthur H. Aufses   +3 more
openalex   +2 more sources

Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy. [PDF]

, 1985
G A Trotter, G R Morgan, A. Cooper, N Kirkham, J. M. A. Whitehouse, I Taylor   +5 more
openalex   +1 more source

ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways

Advanced Science, EarlyView.
Zinc‐finger MYND‐type‐containing 8 (ZMYND8) activates the transcription of CCAAT/enhancer‐binding protein epsilon by recognizing dimethylation of lysine 36 in histone H3 through its Pro‐Trp‐Trp‐Pro domain, thereby inhibiting adaptive unfolded protein response pathways to suppress the proliferation and invasion of multiple myeloma (MM) cells ...
Jiaxuan Xu, Xiaoqing Dong, Yue Peng, Jie Yan, Peipei Xu, Feiyu Li, Suwen Zhang, Lanxin Chen, Xingjun Meng, Kangning Wang, Mengying Xing, Wenyang Li, David C. S. Huang, Quan Zhao, Bing Chen   +14 more
wiley   +1 more source